US Stock MarketDetailed Quotes

IOBT IO Biotech

Watchlist
  • 1.640
  • +0.040+2.50%
Close Aug 23 16:00 ET
  • 1.650
  • +0.010+0.61%
Post 20:02 ET
108.04MMarket Cap-1301P/E (TTM)

IO Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-1.46%21.53M
12.68%20.2M
28.03%91.44M
38.23%28.18M
48.02%23.48M
20.32%21.85M
5.37%17.92M
73.22%71.42M
-4.70%20.39M
125.29%15.87M
Selling and administrative expenses
6.30%5.69M
-2.29%5.89M
-3.37%23.61M
7.67%6.41M
-0.24%5.83M
-9.89%5.35M
-10.14%6.02M
120.52%24.44M
20.20%5.96M
100.51%5.84M
-General and administrative expense
6.30%5.69M
-2.29%5.89M
-3.37%23.61M
7.67%6.41M
-0.24%5.83M
-9.89%5.35M
-10.14%6.02M
120.52%24.44M
20.20%5.96M
100.51%5.84M
Research and development costs
-3.97%15.85M
20.26%14.31M
44.36%67.83M
50.83%21.77M
76.16%17.66M
34.99%16.5M
15.47%11.9M
55.83%46.99M
-12.21%14.43M
142.78%10.02M
Operating profit
1.46%-21.53M
-12.68%-20.2M
-28.03%-91.44M
-38.23%-28.18M
-48.02%-23.48M
-20.32%-21.85M
-5.37%-17.92M
-73.22%-71.42M
4.70%-20.39M
-125.29%-15.87M
Net non-operating interest income expense
9.62%1.31M
57.30%1.62M
430.30%5.88M
148.91%1.95M
350.66%1.71M
2,035.71%1.2M
1,051.85%1.03M
407.20%1.11M
618.54%783K
665.67%379K
Non-operating interest income
9.62%1.31M
57.30%1.62M
316.80%5.88M
149.87%1.95M
273.74%1.71M
656.96%1.2M
6,753.33%1.03M
--1.41M
--780K
--457K
Non-operating interest expense
----
----
--0
--0
--0
----
----
-16.34%302K
-101.99%-3K
16.42%78K
Other net income (expense)
-1,000.00%-90K
-279.07%-462K
154.62%331K
-22.41%405K
-293.10%-342K
103.50%10K
1,390.00%258K
100.50%130K
71.15%522K
-103.29%-87K
Gain on sale of security
-1,000.00%-90K
-279.07%-462K
154.62%331K
-22.41%405K
-293.10%-342K
103.50%10K
1,390.00%258K
-59.25%130K
5,120.00%522K
-611.76%-87K
Income before tax
1.62%-20.31M
-14.45%-19.04M
-21.44%-85.23M
-35.34%-25.83M
-42.03%-22.12M
-12.26%-20.65M
2.92%-16.64M
-3.50%-70.19M
10.15%-19.08M
-249.01%-15.57M
Income tax
-29.70%374K
2.22%415K
-33.07%852K
-64.24%353K
-481.74%-439K
411.54%532K
515.15%406K
1,772.06%1.27M
1,351.47%987K
115K
Net income
2.32%-20.69M
-14.16%-19.46M
-20.47%-86.08M
-30.45%-26.18M
-38.19%-21.68M
-14.51%-21.18M
0.93%-17.04M
-5.27%-71.46M
5.81%-20.07M
-251.59%-15.69M
Net income continuous Operations
2.32%-20.69M
-14.16%-19.46M
-20.47%-86.08M
-30.45%-26.18M
-38.19%-21.68M
-14.51%-21.18M
0.93%-17.04M
-5.27%-71.46M
5.81%-20.07M
-251.59%-15.69M
Minority interest income
Net income attributable to the parent company
2.32%-20.69M
-14.16%-19.46M
-20.47%-86.08M
-30.45%-26.18M
-38.19%-21.68M
-14.51%-21.18M
0.93%-17.04M
-5.27%-71.46M
5.81%-20.07M
-251.59%-15.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
2.32%-20.69M
-14.16%-19.46M
-20.47%-86.08M
-30.45%-26.18M
-38.19%-21.68M
-14.51%-21.18M
0.93%-17.04M
4.71%-71.46M
10.44%-20.07M
-140.06%-15.69M
Basic earnings per share
58.11%-0.31
49.15%-0.3
20.16%-1.98
43.23%-0.3974
20.37%-0.43
-15.63%-0.74
1.67%-0.59
85.66%-2.48
10.00%-0.7
-112.59%-0.54
Diluted earnings per share
58.11%-0.31
49.15%-0.3
20.16%-1.98
43.23%-0.3974
20.37%-0.43
-15.63%-0.74
1.67%-0.59
85.66%-2.48
10.00%-0.7
-112.59%-0.54
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -1.46%21.53M12.68%20.2M28.03%91.44M38.23%28.18M48.02%23.48M20.32%21.85M5.37%17.92M73.22%71.42M-4.70%20.39M125.29%15.87M
Selling and administrative expenses 6.30%5.69M-2.29%5.89M-3.37%23.61M7.67%6.41M-0.24%5.83M-9.89%5.35M-10.14%6.02M120.52%24.44M20.20%5.96M100.51%5.84M
-General and administrative expense 6.30%5.69M-2.29%5.89M-3.37%23.61M7.67%6.41M-0.24%5.83M-9.89%5.35M-10.14%6.02M120.52%24.44M20.20%5.96M100.51%5.84M
Research and development costs -3.97%15.85M20.26%14.31M44.36%67.83M50.83%21.77M76.16%17.66M34.99%16.5M15.47%11.9M55.83%46.99M-12.21%14.43M142.78%10.02M
Operating profit 1.46%-21.53M-12.68%-20.2M-28.03%-91.44M-38.23%-28.18M-48.02%-23.48M-20.32%-21.85M-5.37%-17.92M-73.22%-71.42M4.70%-20.39M-125.29%-15.87M
Net non-operating interest income expense 9.62%1.31M57.30%1.62M430.30%5.88M148.91%1.95M350.66%1.71M2,035.71%1.2M1,051.85%1.03M407.20%1.11M618.54%783K665.67%379K
Non-operating interest income 9.62%1.31M57.30%1.62M316.80%5.88M149.87%1.95M273.74%1.71M656.96%1.2M6,753.33%1.03M--1.41M--780K--457K
Non-operating interest expense ----------0--0--0---------16.34%302K-101.99%-3K16.42%78K
Other net income (expense) -1,000.00%-90K-279.07%-462K154.62%331K-22.41%405K-293.10%-342K103.50%10K1,390.00%258K100.50%130K71.15%522K-103.29%-87K
Gain on sale of security -1,000.00%-90K-279.07%-462K154.62%331K-22.41%405K-293.10%-342K103.50%10K1,390.00%258K-59.25%130K5,120.00%522K-611.76%-87K
Income before tax 1.62%-20.31M-14.45%-19.04M-21.44%-85.23M-35.34%-25.83M-42.03%-22.12M-12.26%-20.65M2.92%-16.64M-3.50%-70.19M10.15%-19.08M-249.01%-15.57M
Income tax -29.70%374K2.22%415K-33.07%852K-64.24%353K-481.74%-439K411.54%532K515.15%406K1,772.06%1.27M1,351.47%987K115K
Net income 2.32%-20.69M-14.16%-19.46M-20.47%-86.08M-30.45%-26.18M-38.19%-21.68M-14.51%-21.18M0.93%-17.04M-5.27%-71.46M5.81%-20.07M-251.59%-15.69M
Net income continuous Operations 2.32%-20.69M-14.16%-19.46M-20.47%-86.08M-30.45%-26.18M-38.19%-21.68M-14.51%-21.18M0.93%-17.04M-5.27%-71.46M5.81%-20.07M-251.59%-15.69M
Minority interest income
Net income attributable to the parent company 2.32%-20.69M-14.16%-19.46M-20.47%-86.08M-30.45%-26.18M-38.19%-21.68M-14.51%-21.18M0.93%-17.04M-5.27%-71.46M5.81%-20.07M-251.59%-15.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 2.32%-20.69M-14.16%-19.46M-20.47%-86.08M-30.45%-26.18M-38.19%-21.68M-14.51%-21.18M0.93%-17.04M4.71%-71.46M10.44%-20.07M-140.06%-15.69M
Basic earnings per share 58.11%-0.3149.15%-0.320.16%-1.9843.23%-0.397420.37%-0.43-15.63%-0.741.67%-0.5985.66%-2.4810.00%-0.7-112.59%-0.54
Diluted earnings per share 58.11%-0.3149.15%-0.320.16%-1.9843.23%-0.397420.37%-0.43-15.63%-0.741.67%-0.5985.66%-2.4810.00%-0.7-112.59%-0.54
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg